Arnold Chiari Malformation: the Otological Assessment as an Objective Criteria for Surgical Treatment

Overview

The aim of this study is to compare the value of multifrequency tympanometry between patients with surgical indication of treatment for a Chiari type I malformation and healthy volunteers.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Non-Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Diagnostic
    • Masking: None (Open Label)
  • Study Primary Completion Date: February 17, 2020

Detailed Description

Prevalence of Chiari type I malformation in population is between 0.1% and 0.5%. Chiari type I malformation is responsive in perturbation of the cerebro spinal fluid flow at the cranio-cervical junction. Those perturbations caused headaches, and various otological symptoms (dizziness, tinnitus, vertigo, nystagmus, hypoacousis…). The surgical treatment consists in an occipital craniotomy to restore the cerebro spinal fluid flow at the cranio-cervical junction. Symptoms are due to increasing of the pressure in the cerebellar fossa. 81% of the patients with Chiari type 1 malformation suffer of sub clinical otological perturbations especially alteration of the vestibular test. In the literature, hearing performance could be normalized after posterior fossa decompression. Furthermore, the multifrequency tympanometry measurement and particularly the width of conductance tympanograms at 2 kHz shows that variations of the cerebro spinal fluid pressure have consequences on the pressure of the perilymph. Investigator's hypothesis is that tympanometry (conductance) could be an effective test to show the variation of the cerebro spinal fluid pressure.

Interventions

  • Diagnostic Test: Multifrequency tympanometry at Inclusion
    • Multifrequency tympanometry measurement and particularly width of conductance tympanograms at 2 kHz will be performed for both group at inclusion
  • Diagnostic Test: Multifrequency tympanometry 6 month after surgery
    • Multifrequency tympanometry measurement and particularly width of conductance tympanograms at 2 kHz will be performed 6 months after surgery for Chiari type I malformation patient

Arms, Groups and Cohorts

  • Experimental: Patients with Chiari type 1 malformation
    • Tympanometry measurement at inclusion and 6 months after surgery
  • Experimental: Healthy volunteers
    • Tympanometry measurement at inclusion. Every healthy volunteer will be match with a patient for his age and his BMI (body mass index).

Clinical Trial Outcome Measures

Primary Measures

  • Width of conductance tympanograms at 2 kHz measurement
    • Time Frame: Inclusion

Secondary Measures

  • Multifrequency tympanometry
    • Time Frame: Inclusion and 6 months after surgery for patients with an indication of surgical management for a Chiari type I malformation
  • Resonance frequency
    • Time Frame: Inclusion and 6 months after surgery for patients with an indication of surgical management for a Chiari type I malformation
  • Audiometric parameters
    • Time Frame: Inclusion and 6 months after surgery for patients with an indication of surgical management for a Chiari type I malformation
  • Otological symptoms
    • Time Frame: Inclusion and 6 months after surgery for patients with an indication of surgical management for a Chiari type I malformation
  • Pain measurement with Headache Impact Test
    • Time Frame: Inclusion and 6 months after surgery for patients with an indication of surgical management for a Chiari type I malformation
  • Cerebro spinal fluid pressure of the cranio cervical junction
    • Time Frame: Inclusion and 6 months after surgery for patients with an indication of surgical management for a Chiari type I malformation

Participating in This Clinical Trial

Inclusion Criteria

  • Chiari type I malformation proved at MRI or CT-scan with an indication of cranio cervical decompression. – Patients between 18 and 60 years old. – Patient should benefit of the national health care system – Agreement of the patient Inclusion criteria for healthy volunteers: – Between 18 and 60 years old. – Free of otologic pathology – Benefit of the national health care system – Agreement of the volunteers Exclusion criteria:

  • Acute hydrocephaly – Other type of Chiari disease (induced…) – Medical history of neurosurgery – Contraindication for MRI – Cophosis – Chronic otitis – Medical history of ontological surgery – Tympanic perforation – Disturbance of tonal audiometry with air bone more than 20dB in 4 frequencies with abolition of stapedial reflex – Pregnant women or nursing women – Protected adults by French laws Exclusion criteria for healthy volunteers: – Medical history of neurosurgery – Cophosis – Chronic otitis – Medical history of ontological surgery – Tympanic perforation – Disturbance of tonal audiometry with air bone more than 20dB in 4 frequencies with abolition of stapedial reflex – Pregnant women or nursing women – Medical history of Chiari malformation – Chronic headaches or neck pain – Protected adults by French laws

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 60 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • University Hospital, Bordeaux
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Antoine BENARD, MD, Study Chair, USMR – CHU de Bordeaux

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.